000 | 01169 a2200325 4500 | ||
---|---|---|---|
005 | 20250514195711.0 | ||
264 | 0 | _c20041109 | |
008 | 200411s 0 0 eng d | ||
022 | _a1499-3872 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJiang, Xiao-Ting | |
245 | 0 | 0 |
_aDetection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer. _h[electronic resource] |
260 |
_bHepatobiliary & pancreatic diseases international : HBPD INT _cAug 2004 |
||
300 |
_a464-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntigens, Tumor-Associated, Carbohydrate _xblood |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aCA-125 Antigen _xblood |
650 | 0 | 4 |
_aCA-19-9 Antigen _xblood |
650 | 0 | 4 |
_aCarcinoembryonic Antigen _xblood |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMucin-1 _xblood |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPancreatic Neoplasms _xblood |
650 | 0 | 4 | _aSensitivity and Specificity |
700 | 1 | _aTao, Hou-Quan | |
700 | 1 | _aZou, Shou-Chun | |
773 | 0 |
_tHepatobiliary & pancreatic diseases international : HBPD INT _gvol. 3 _gno. 3 _gp. 464-8 |
|
999 |
_c15012609 _d15012609 |